DAVID WICHMAN: Open Payments
NPI 1760695290 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$144,637 in 157 payments from 12 companies in 2025. Trend: 2023 $165,335 · 2024 $72,762 · 2025 $144,637
Speaker / faculty: $105,750Honoraria: $25,575Travel & lodging: $7,358Food & beverage: $5,954
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 110 | $113,466 |
| Axsome Therapeutics, Inc. | 26 | $27,566 |
| Brainsway USA INC | 1 | $3,120 |
| Janssen Pharmaceuticals, Inc | 2 | $104 |
| Alkermes, Inc. | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: VRAYLAR, Auvelity, Deep TMS System, SPRAVATO, ARISTADA, REXULTI, FANAPT, INGREZZA.
Industry payments across KS — which companies pay providers there.
